Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) Posts Basic Consolidated EPS Of $0.6239

0

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)managed to report annual basic consolidated EPS of $0.6239, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $0.6239 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.096.

EPS contribution from parent

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) received of $0.6239 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) contributed EPS of $0.6239 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $0.6239.

What About Basic net EPS

The basic net EPS that Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) reported for the year ended 2015-12-31 stood at $0.62. For the quarter ended 2015-12-31, the company posted basic net EPS of $0.62.

What About Consolidated Diluted EPS?

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $0.5964. For the quarter ended 2015-12-31 the metric was$0.5964.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $0.5964 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $0.5964.

Net diluted EPS

Net diluted EPS posted by Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) for the year ended 2015-12-31 was $0.54. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $0.54.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) said that it parent company boosted its diluted EPS by$0.5964 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $0.5964.

The company reported net basic EPS of $0.62 for the year ended 2015-12-31 and net basic EPS of $0.62 for the quarter ended 2015-12-31.

The number of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 70.242. That compares with 70.242 basic shares outstanding for the quarter ended 2015-12-31.

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) had 73.483 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 73.483.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 164 times, 1 visits today)